| Jordan A Doan, | |
|
2401 Central Ave, Dodge City, KS 67801-6206 | |
| (620) 227-8193 | |
| Not Available |
| Full Name | Jordan A Doan |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 2401 Central Ave, Dodge City, Kansas |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104591718 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 1-103822 (Kansas) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Jordan A Doan, 2401 Central Ave, Dodge City, KS 67801-6206 Ph: (620) 227-8193 | Jordan A Doan, 2401 Central Ave, Dodge City, KS 67801-6206 Ph: (620) 227-8193 |
News Archive
The first word Timur ever uttered was "cat". For all of his 8 years, Timur has been fascinated by animals and dinosaurs; he loves to watch Animal Planet and the Discovery Channel. So when he was told he could have his most heartfelt wish thanks to The Children's Wish Foundation of Canada, animals were certain to be an important part of it.
National guidelines assume that all patients who're diagnosed with clinical sepsis in an emergency department will be admitted to the hospital for additional care, but new research has found that many more patients are being treated and released from the ED for outpatient follow-up than previously recognized.
An interdisciplinary team of researchers from Columbia University, led by Ken Shepard, professor of electrical engineering and biomedical engineering at Columbia Engineering and including Virginia W. Cornish, Helena Rubinstein Professor of Chemistry, and Lars Dietrich, assistant professor of biological sciences, has won a prestigious $1 million three-year grant from the W. M. Keck Foundation to advance their research in combining biological components with solid-state electronics, creating new systems that exploit the advantages of both.
Colorectal cancer is the third most common form of cancer globally and the second most common cause of cancer deaths. The chance of a cure is high if the cancer is detected early enough, but early detection is not a given. Researchers from VIB and KU Leuven - together with various European oncology centers, including UZ Leuven - have identified bio-markers that can be incorporated in a new diagnostic test.
Agena Bioscience, Inc., which recently acquired the Bioscience business of Sequenom, Inc., today announced expansion of the UltraSEEK™ technology, the first ultrasensitive somatic mutation detection technology for high-throughput and definitive interrogation of rare mutations that occur at less than 1% abundance in matched tissue, circulating plasma, and tumor samples.
› Verified 7 days ago
Ms. Sara Jane Wilhite, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 N 14th Ave, Dodge City, KS 67801 Phone: 620-225-6140 Fax: 620-225-8813 | |
Krista Morrison, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2401 Central Ave, Dodge City, KS 67801 Phone: 620-227-8193 | |
Janine Kilian Forrest, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 N 14th Ave, Dodge City, KS 67801 Phone: 620-225-6095 Fax: 620-225-6578 | |
Mara Lee Goebel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2401 Central Ave, Dodge City, KS 67801 Phone: 620-227-8193 Fax: 620-227-8006 | |
Son Nhut Loi, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1700 N 14th Ave, Dodge City, KS 67801 Phone: 620-225-6140 | |
Mr. James Steven Mccrery, R.PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 N 14th Ave, Dodge City, KS 67801 Phone: 620-225-6095 Fax: 620-225-6578 |